Absci (ABSI) Asset Utilization Ratio (2021 - 2026)

Absci's (ABSI) quarterly Asset Utilization Ratio came in at 0.01 in Q1 2026, down 58.71% year-on-year from 0.02 in Q1 2025, and down 26.56% quarter-over-quarter from 0.01 in Q4 2025.

Absci (ABSI) Asset Utilization Ratio (2021 - 2026) Analysis & Trends

Absci has disclosed Asset Utilization Ratio across 6 years of filings, most recently posting 0.01 for Q1 2026.

  • Asset Utilization Ratio for Q1 2026 came in at 0.01, down 58.71% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.01 (down 58.71% YoY), and the FY2025 annual result was 0.01, down 38.1% from the prior year.
  • Asset Utilization Ratio came in at 0.01 for Q1 2026 at Absci, down from 0.01 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.03 in Q2 2023 to a low of 0.01 in Q1 2022.
  • The 5-year median for Asset Utilization Ratio is 0.02 (2023), against an average of 0.02.
  • Across the five-year window, Asset Utilization Ratio jumped 187.31% in 2023 and sank 58.71% in 2026, its largest moves.
  • Absci's Asset Utilization Ratio stood at 0.01 in 2022, then jumped by 115.76% to 0.03 in 2023, then dropped by 19.86% to 0.02 in 2024, then tumbled by 39.91% to 0.01 in 2025, then retreated by 26.56% to 0.01 in 2026.
  • The last three Asset Utilization Ratio figures came in at 0.01 (Q1 2026), 0.01 (Q4 2025), and 0.01 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 0.55
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.60
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 1,422.00
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 0.47
9 Abivax 91.96 Bn 91.96 Bn - -
10 Absci 1.13 Bn 1.01 Bn - 0.01

Historic Data

Download Data
DateValue
Mar 31, 2026 0.01
Dec 31, 2025 0.01
Sep 30, 2025 0.01
Jun 30, 2025 0.02
Mar 31, 2025 0.02
Dec 31, 2024 0.02
Sep 30, 2024 0.02
Jun 30, 2024 0.01
Mar 31, 2024 0.02
Dec 31, 2023 0.03
Sep 30, 2023 0.02
Jun 30, 2023 0.03
Mar 31, 2023 0.02
Dec 31, 2022 0.01
Sep 30, 2022 0.01
Jun 30, 2022 0.01
Mar 31, 2022 0.01
Dec 31, 2021 0.01
Sep 30, 2021 0.02